AL amyloidosis manifesting as systemic lymphadenopathy. - Wikidata - awgldk - TriplyDB

AL amyloidosis manifesting as systemic lymphadenopathy.

AL amyloidosis manifesting as systemic lymphadenopathy.

http://www.wikidata.org/entity/Q37165349

about

Lymphadenopathy as a manifestation of amyloidosis: a case series.Localized lymph node light chain amyloidosis.Bilateral Chronic Subdural Nontraumatic Hematoma in a Woman Affected by AL Amyloidosis.Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging.Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis Surgical removal of amyloid-laden lymph nodes: a possible therapeutic approach in a primary systemic AL amyloidosis patient with focal lymphadenopathy Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis

P2860

Q38248110-6AFDE0CF-787C-4960-859C-F3853398CC95 Q38448546-A0559C05-B20B-424C-84DD-D8C9AEB71A53 Q42408995-D4683A0B-2949-4856-9637-DC5FFDA3906F Q48097450-69B4E276-8CA2-4AEB-A248-A066F09F52E2 Q58124996-28483ED2-5A8B-4051-B8CE-8BF893D3E084 Q58182330-91F46E7A-5791-48EC-862E-17321EE96BC2 Q58260919-5D1AB69D-3C7E-4EFB-83FF-1BD7F882641C

P2860

AL amyloidosis manifesting as systemic lymphadenopathy.

http://www.wikidata.org/entity/Q37165349

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

AL amyloidosis manifesting as systemic lymphadenopathy.

@en

AL amyloidosis manifesting as systemic lymphadenopathy.

@nl

type

label

AL amyloidosis manifesting as systemic lymphadenopathy.

@en

AL amyloidosis manifesting as systemic lymphadenopathy.

@nl

prefLabel

AL amyloidosis manifesting as systemic lymphadenopathy.

@en

AL amyloidosis manifesting as systemic lymphadenopathy.

@nl

P1433

Q37165349-8C9F3D78-6FAC-492B-936A-25317441A12F

P1476

Q37165349-7A21C992-E21F-4A3B-BA7B-CBFF36C3449D

P2093

Q37165349-0FD9F778-3BEF-40C6-ABE6-B099A2539B84

Q37165349-4A0EA315-D66B-4F23-BA3C-439A3D08CCC8

Q37165349-665C419F-48E6-4CFB-B52D-423F488A9BBD

Q37165349-6B1F560D-807F-4C8D-AF9A-ACB18CBEECEC

Q37165349-7C929A6E-DEDB-4749-A201-11D8C42BFE16

Q37165349-B3B2FCA0-1C50-417F-BC71-FDCF4DE6247C

Q37165349-D6306D18-58DD-47AA-8A02-7C256C0A30F5

Q37165349-DF7162D8-FF34-4B52-81F5-C837427CE9DF

P2860

Q37165349-1C678BF7-3B7E-43EF-854D-663C56453BE9

Q37165349-385F9CF5-C027-4202-BC17-FCC759C5F82F

Q37165349-525353BC-5EDA-419C-A6B9-FE67D8EBDAF3

Q37165349-56E01646-A6C8-44A8-AB85-DCEB749A9F42

Q37165349-5B2CC809-5FEF-40EE-93F8-54718F0E4BEB

Q37165349-699F2BE0-19DA-4685-B62A-74020DEE84B7

Q37165349-7D179EC7-39F9-4621-B95D-B32CCA490871

Q37165349-810B961B-75B7-4893-8A9E-CDED8D268EF5

Q37165349-A32891D6-CEE1-4251-B28B-540E4028DC8B

Q37165349-E234DA4B-E9F3-41F1-A79C-DBA07C3B16DE

P304

Q37165349-57034FCB-B3D8-477E-9A89-E7BD5BDC03B3

P31

Q37165349-0F236898-8399-42D9-B3FE-19AE4DF80477

P356

Q37165349-ABEE0BB3-6D46-424C-84E8-466D34C04224

P433

Q37165349-7A15FF52-CCB5-4032-80B3-9726A1EB57D1

P478

Q37165349-44E689FE-B57F-45A8-9F02-CEC549F17FF0

P577

Q37165349-6FD7D737-3473-4ACB-9D3B-4A1D0FBE90C1

P698

Q37165349-466670A2-C36A-4A87-BFBB-8324E67B6439

P356

13506120802006047

P1433

P1476

AL amyloidosis manifesting as systemic lymphadenopathy.

@en

P2093

Masayuki Matsuda

http://www.w3.org/2001/XMLSchema#string

Nagaaki Katoh

http://www.w3.org/2001/XMLSchema#string

Shu-ichi Ikeda

http://www.w3.org/2001/XMLSchema#string

Takahisa Gono

http://www.w3.org/2001/XMLSchema#string

Takuhiro Yoshida

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Yamada

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Shimojima

http://www.w3.org/2001/XMLSchema#string

Yoshinobu Hoshii

http://www.w3.org/2001/XMLSchema#string

P2860

Immunoglobulin related amyloidosis presenting as isolated lymph node and pulmonary involvement.

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.

Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.

Stem cell transplantation for the management of primary systemic amyloidosis.

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Autologous stem cell transplantation and IgM amyloidosis.

Treatment of Waldenström's macroglobulinemia with rituximab.

Primary amyloidosis presenting with massive generalized lymphadenopathy.

Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis.

Amyloid lymphadenopathy.

P304

117-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13506120802006047

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18484338

http://www.w3.org/2001/XMLSchema#string